AzTrials
AzTrials

Eye Movement Desensitization and ReprocessingNCT06878807

Exploring the Role of Working Memory Saturation in Eye Movement Desensitization and Reprocessing (EMDR) Using the Eye Blink Conditioning Paradigm

A study testing eye movement and TMT-B in people with Eye Movement Desensitization and Reprocessing, run by Hospital Clinic of Barcelona at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Eye Movement Desensitization and Reprocessing (EMDR) is a well-established, evidence-based treatment for posttraumatic stress disorder (PTSD). It is endorsed by leading organizations such as the American Psychiatric Association and the World Health Organization. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
What is being tested?
eye movement and TMT-B
Could I receive a placebo?
No, everyone receives an active treatment
How many people
112 participants
Where
1 siteSpain
Study dates
1 Apr 2022to 1 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age between 18 and 65 years
  • Provide informed consent

Who cannot join

  • Prior exposure to EMDR therapy or eye movement (EM) experiments
  • Positive diagnosis of PTSD or other Axis I disorders as determined by the Mini-International Neuropsychiatric Interview (MINI)
  • Hearing or visual impairments

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Hospital Clinic de Barcelona

    Barcelona, Barcelona

Other trials in Spain

About this study

Official title: Eye Movements and the Extinction Procedure in Eyeblink Conditioning: A Possible Mechanism of Action for Eye Movement Desensitization and Reprocessing

Eye Movement Desensitization and Reprocessing (EMDR) is a well-established, evidence-based treatment for posttraumatic stress disorder (PTSD). It is endorsed by leading organizations such as the American Psychiatric Association and the World Health Organization. During EMDR therapy, patients focus on recalling traumatic events while simultaneously engaging with an external stimulus. Specifically, patients undergo lateral eye movements. This process is believed to reduce the vividness and emotional intensity of traumatic memories by addressing and desensitizing their cognitive, emotional, and physical components. Despite its proven efficacy in treating PTSD, the precise mechanisms underlying these therapeutic effects remain not fully understood.

Several hypotheses have been proposed to explain the efficacy of EMDR. Among them, the working memory hypothesis is particularly influential and is supported by a substantial body of research. This hypothesis suggests that aversive memories and fear, when recalled, occupy limited memory resources. Therefore, performing a task, such as eye movements, during the recall of the traumatic experience would result in a competition for limited memory resources, leading to a decrease in the vividness and emotional intensity of the traumatic memory. Consequently, the dual task inherent in EMDR is thought to facilitate a rapid elimination of the emotional responses triggered by the traumatic memory, allowing patients to alleviate the physical and psychological distress associated with the trauma.

Read more

Measuring the effects of an EM intervention through a standardized protocol could clarify the conditions under which the intervention is most effective and elucidate the potential mechanisms of EMDR. In this context, the Eye Blink Conditioning (EBC) task, a well-established and standardized conditioning paradigm, seems relevant for testing the working memory hypothesis.

In the EBC task, eyelid closure is measured in response to a corneal air puff, which acts as the unconditioned stimulus. The unconditioned stimulus is paired with a neutral stimulus, a tone, which becomes a conditioned stimulus by eliciting a conditioned response similar to that produced by the unconditioned stimulus. After the conditioning phase, participants undergo the extinction phase. In this phase, the conditioned stimulus is presented without the unconditioned stimulus for many trials, and the main objective is to measure how many trials it takes for the participants to eliminate the previous associative learning between the aversive stimulus (air puff) and the conditioned stimulus (tone).

This study aimed to explore whether the effectiveness of a straightforward eye movement intervention in accelerating extinction is influenced by the working memory hypothesis. The hypothesis is that the enhancement of extinction learning is dependent on working memory saturation. Understanding the role of working memory saturation in the effectiveness of eye movements during extinction learning could provide critical insights into the working memory hypothesis as a potential key mechanism underlying the efficacy of EMDR therapy.

Being tested
eye movement, TMT-B

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • eye movementBehavioural

    Participants underwent EM tasks during the first 30 seconds of the extinction phase. All participants in this group experienced identical EM conditions in terms of speed and duration.

  • TMT-BBehavioural

    Participants performed the Trail Making Test B (TMT-B).

Study groups in NCT06878807
Study groupRoleWhat they receive
Eye Movement InterventionExperimentalParticipants underwent EM tasks during the first 30 seconds of the extinction phase. All participants in this group experienced identical EM conditions in terms of speed and duration
Receives: Behavioral: eye movement
TMT-BActive comparatorParticipants performed the Trail Making Test B (TMT-B).
Receives: Behavioral: TMT-B
Control groupNo interventionParticipants engaged in no additional task. These subjects were told to focus their gaze on a wall in front of them.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Extinction Learning Differences

    Assesses the number of conditioned responses (CR) during the initial block of the extinction phase.

    Measured: Baseline

Secondary outcomes (4)
  1. Latency of Eyeblink Conditioned Response (CR) During the Eye Blink Conditioning Task

    Latency assesses the time of onset of the CR following the conditioned stimulus (CS). Data will be reported as the mean CR onset time per block.

    Measured: Baseline

  2. Intensity of Eyelid Closure During the Eye Blink Conditioning Task

    Intensity assesses the peak amplitude of the CR during conditioning trials. Data will be reported as the mean CR peak amplitude per block.

    Measured: Baseline

  3. Trauma History (Childhood Trauma Questionnaire)

    • Childhood Trauma Questionnaire (CTQ): Assesses childhood traumatic exposure. Higher scores indicate greater traumatic exposure.

    Measured: Baseline

  4. Trauma History (Life Events Checklist-5)

    • Life Events Checklist for DSM-5 (LEC-5): Evaluates exposure to 15 different types of traumatic experiences. Responses indicate whether the participant has experienced each event (Yes/No).

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Mar 2025
  2. Study start1 Apr 2022
  3. Primary completion1 Dec 2024
  4. Study completion1 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
112 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06878807
Sponsor's protocol ID
HCB/2021/0283
Status last verified
Sep 2025
First submitted
6 Feb 2025
Last updated
16 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing eye movement and TMT-B in people with Eye Movement Desensitization and Reprocessing, run by Hospital Clinic of Barcelona at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Extinction Learning Differences (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2025; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in